A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities - CNRS - Centre national de la recherche scientifique
Journal Articles Disease Models & Mechanisms Year : 2023

A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities

Abstract

p53 (encoded by Trp53) is a tumor suppressor, but mouse models have revealed that increased p53 activity may cause bone marrow failure, likely through dimerization partner, RB-like, E2F4/E2F5 and MuvB (DREAM) complex-mediated gene repression. Here, we designed a systematic approach to identify p53-DREAM pathway targets, the repression of which might contribute to abnormal hematopoiesis. We used Gene Ontology analysis to study transcriptomic changes associated with bone marrow cell differentiation, then chromatin immunoprecipitation-sequencing (ChIP-seq) data to identify DREAM-bound promoters. We next created positional frequency matrices to identify evolutionary conserved sequence elements potentially bound by DREAM. The same approach was developed to find p53-DREAM targets associated with brain abnormalities, also observed in mice with increased p53 activity. Putative DREAM-binding sites were found for 151 candidate target genes, of which 106 are mutated in a blood or brain genetic disorder. Twenty-one DREAM-binding sites were tested and found to impact gene expression in luciferase assays, to notably regulate genes mutated in dyskeratosis congenita (Rtel1), Fanconi anemia (Fanca), Diamond–Blackfan anemia (Tsr2), primary microcephaly [Casc5 (or Knl1), Ncaph and Wdr62] and pontocerebellar hypoplasia (Toe1). These results provide clues on the role of the p53-DREAM pathway in regulating hematopoiesis and brain development, with implications for tumorigenesis.
Fichier principal
Vignette du fichier
rakotoparedmm.pdf (11.18 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-04265058 , version 1 (30-10-2023)

Licence

Identifiers

Cite

Jeanne Rakotopare, Vincent Lejour, Carla Duval, Eliana Eldawra, Hugues Escoffier, et al.. A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. Disease Models & Mechanisms, 2023, 16 (10), ⟨10.1242/dmm.050376⟩. ⟨hal-04265058⟩
48 View
25 Download

Altmetric

Share

More